KFF reports BPC-157 injuries as MAHA pushes to loosen peptide rules
An unpublished analysis of de-identified electronic health records found more than 1,000 people told doctors they had used BPC-157 since 2020.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 13 17:04 ETSource: The Gilmer Mirror
The wire
- 01KFF Health News profiles a weightlifter who says intranasal BPC-157 bought from an online vendor left him with months of fatigue, anxiety and eye and muscle twitching.
- 02BPC-157 has not been through clinical trials or won FDA approval, yet podcasters and wellness clinics promote it; health secretary Robert F. Kennedy Jr. and MAHA allies want barriers to peptide access lowered.
- 03The electronic health record analysis showing growing use, particularly among white males, has not been peer reviewed, and vendors still label the product research-use-only.
From the source
Read at gilmermirror.comPeople Say These Peptides Hurt Them. Their Stories Are Muffled in MAHA’s Push for Medical Freedom.
After the third day of squirting an experimental drug up his nose, Dylan Meetze felt horrible.
